Latest Blog Posts Tagged "Parkinson's Progression Markers Initiative"
March 22, 2018
In the latest "Ask the MD" video, Dr. Dolhun talks about how doctors diagnose Parkinson's and how a tool called a biomarker may help.
March 20, 2018
The Lancet Neurology calls the AMP PD program the 'most ambitious initiative so far to find a cure for Parkinson's.'
January 30, 2018
The Michael J. Fox Foundation, National Institutes of Health and five industry partners unite to find molecular difference in Parkinson's.
October 13, 2017
Analysis from the MJFF-led PPMI points to potential use of these biomarkers for testing drug engagement but likely not for tracking short-term progression.
October 03, 2017
David Levine, MD, MPH, shares his experiences as a participant in the Levodopa Response Trial and thoughts on PD scientists using his data to advance research.
August 17, 2017
A new paper shows 67% of study participants who showed smell loss and dopamine loss in the brain developed PD over a four-year period. This strategy could help select people for research studies.
August 02, 2017
Two studies using data from the MJFF-led Parkinson's Progression Markers Initiative point to brain imaging scans that could help advance drug trials.
July 31, 2017
A new study was launched to investigate if man's best friend can play a role in PD diagnosis.
June 23, 2017
Researchers have developed a tool to predict cognitive decline in PD for use in designing clinical studies. The team analyzed data from multiple studies including PPMI.
June 02, 2017
Sue Lifschiz of Santa Rosa, California was diagnosed with PD in 2002. She joined PPMI to find a biomarker for earlier diagnosis and better disease tracking.